Luyan Pharma Co Ltd (002788) — Cash Flow Quality Index
Luyan Pharma Co Ltd (002788) has a Cash Flow Quality Index of 1.83x as of September 2025. Operating cash flow of CN¥118.98 Million exceeds net income of CN¥65.14 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Luyan Pharma Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Luyan Pharma Co Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Luyan Pharma Co Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Luyan Pharma Co Ltd.
Annual Cash Flow Quality Index for Luyan Pharma Co Ltd (2011–2025)
Year-by-year earnings quality comparison for Luyan Pharma Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.45x | CN¥688.40 Million | CN¥280.88 Million | ▲ +47.6% |
| 2024 | 1.66x | CN¥577.48 Million | CN¥347.70 Million | ▼ -53.8% |
| 2023 | 3.59x | CN¥1.31 Billion | CN¥364.49 Million | ▲ +442.9% |
| 2022 | 0.66x | CN¥232.19 Million | CN¥350.97 Million | ▲ +154.2% |
| 2021 | -1.22x | CN¥-372.02 Million | CN¥304.61 Million | ▼ -523.5% |
| 2020 | 0.29x | CN¥77.22 Million | CN¥267.81 Million | ▲ +111.8% |
| 2019 | -2.44x | CN¥-629.14 Million | CN¥257.51 Million | ▼ -455.7% |
| 2018 | 0.69x | CN¥126.77 Million | CN¥184.58 Million | ▲ +122.3% |
| 2017 | -3.08x | CN¥-447.16 Million | CN¥145.01 Million | ▼ -181.3% |
| 2016 | -1.10x | CN¥-128.03 Million | CN¥116.77 Million | ▼ -57694.7% |
| 2015 | 0.00x | CN¥219.31K | CN¥115.21 Million | ▼ -99.9% |
| 2014 | 1.60x | CN¥177.89 Million | CN¥110.97 Million | ▲ +328.7% |
| 2013 | -0.70x | CN¥-76.47 Million | CN¥109.12 Million | ▼ -94.4% |
| 2012 | -0.36x | CN¥-32.94 Million | CN¥91.38 Million | ▼ -181.9% |
| 2011 | 0.44x | CN¥28.01 Million | CN¥63.62 Million | — |